Authors
Loading...
Randomized trial reveals TGF-β1 and HIPK2 role in worsening kidney damage in diabetic kidney disease, suggesting new treatment avenues.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: